DelveInsight’s ‘Pacemakers Pipeline Insights and Competitive Landscape’ report provides an in-depth assessment of the Pacemakers pipeline, market drivers and barriers, understanding the brand positioning and commercial activities, such as collaborations & licensing deals.
The Pacemakers report reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities.
Key takeaways from the Pacemakers Pipeline report:
As per DelveInsight’s analysis, 90% of the pacemaker devices available in the market are implantable, whereas only 10% of the pacemaker devices can be used externally.
Around 61% of the marketed products have dual chambers.
The continuous development in the Pacemakers market includes leadless Pacemakers and biological Pacemakers that have given rise to a vast pipeline and extensive research studies in this arena.
The major players present in the pacemaker market are Boston Scientific Corporation, Medtronic, Abbott Laboratories, Biotronik SE, MicroPort Corporation, Shree Pacetronix Ltd., OSCOR Inc., Lepu Medical Technology (Beijing) Co., Ltd., Vitatron, Galix Biomedical Instrumentation, Atacor Medical, Inc., BioPace Inc., NuVascular Technologies, among others.
Medtronic and Boston Scientific have the highest number of products present in the market, making them the Pacemakers market leaders.
Medtronic is the only company with the first and only FDA and CE-approved leadless Pacemaker portfolio that is expanding the number of potential candidates in the United States and Europe.
MicroPort Scientific Corporation’s CRM offers the world’s smallest trans venous Pacemaker.
The pipeline devices in the different developmental stages include Biological Pacemakers (BioPace Inc.), Biological Pacemakers (NuVascular Technologies), Leadless Pacemakers (Boston Scientific Corporation), Atacor EV temporary system (Atacor Medical), and Aveir Pacemaker System (Abbott Medical).
On October 08, 2020, Medtronic launched the Azure™ with BlueSync™ Technology pacemaker that can communicate directly with smartphones and tablets. This will help Medtronic expand its product portfolio, making it the largest player in the market.
In July 2020, Abbott received FDA approval for its new generation of connected Pacemakers and defibrillator implants. The MRI-compatible Gallant devices were launched in Europe this past February after Abbott received a CE mark, expanding its portfolio in Pacemakers domain.
Request for Sample to know which Pacemaker device is set to make headlines @ Pacemaker Pipeline and Future Outlook
A pacemaker is a device that tends to regulate the electrical system of the body; it helps in controlling the rhythm of the heart. Modern Pacemakers are equipped with two parts: the pulse generator, which carries the battery and the electronics that help in controlling the heartbeat. The other part comprises the leads that send electrical signals to the heart. Leads are small wires that can be seen traversing from the pulse generator to the heart.
Pacemakers are generally known to control two types of arrhythmias, namely, tachycardia and bradycardia.
Know more @ Pacemakers- Overview, Types, Technology
Demand for Advanced Pacemakers Grows
According to the Centers for Disease Control and Prevention (CDC), every year, more than 655,000 people in the United States die from heart disease, and around 805,000 Americans have a heart attack every year. Out of the total, around 200,000 happen to people who have already had a heart attack. Then, there is a huge burden due to arrhythmia, and it is estimated that approximately 200,000 to 300,000 patients die of arrhythmia per year. This adds a burden to the healthcare facilities and disrupts patient’s lives.
The current forms of Pacemakers are not good at understanding the physiological needs of the body and adapting its pacing according to the individual’s needs, and it is studied that a patient’s heart rate variability provides a better understanding of a person’s health than constant heart rate.
Get in touch to understand what factors are guiding the spur @ Pacemakers Emerging Devices and Key Companies
By the Numbers: Pacemakers in the Pipeline
According to a research article by (Hao et al., 2015), worldwide, there are more than 3 million functioning permanent Pacemakers, and about 600,000 Pacemakers are implanted each year.
The biological form of Pacemakers is considered an exceptionally useful development and is being researched continuously in pre-clinical and clinical stages and are expected to get commercialized in the near future. These forms of Pacemakers are found to have multi-directional benefits for both patients and clinicians. They are developed from embryonic stem cells, offer no immune responses, require no device replacement, and do not indulge in any device or lead failure issues.
A shift in the adoption towards technologically advanced non-invasive ultrasound-based Pacemakers, cardiac resynchronization therapy Pacemakers (CRT-P), and leadless Pacemakers would open numerous opportunities for the pacemaker market. Though, a significant challenge in the adoption of the Pacemakers is the presence of alternative treatments such as cardiac ablation-catheters and cardioverter-defibrillators that are used in tachycardia management.
Let’s discuss more regarding the factors strengthening the Pacemakers Pipeline outlook @ Pacemakers Pipeline Landscape and Forecast
Competitive Assessment of Pacemakers in the Pipeline
Atacor Ev Temporary Pacing System
Atacor Medical, Inc.
TPG (external temporary pacemaker)
Key Companies in Pacemaker Pipeline Landscape
Boston Scientific Corporation
Shree Pacetronix Ltd
Lepu Medical Technology (Beijing) Co., Ltd.
Galix Biomedical Instrumentation
Atacor Medical, Inc.
Know more about the key companies involved @ Key Companies Strengthening the Pacemakers Pipeline
Table of Content
Pacemakers Profiles: Competitive Assessment
Pacemakers: Comparative Benchmarking: By Company
Pacemakers – Commercialization Activity
DelveInsight’s Analytical Perspective
Visit to know more about the report offerings @ Pacemakers Pipeline Domain
The report provides valuable insight for clients venturing into the Pacemaker market and acts as the source of guidance for taking strategic business decisions in the field of the Pacemaker by providing a descriptive overview of Pacemakers and application, including detailed chapters on type of products.
The Pacemakers Pipeline report is a comprehensive account of both marketed and pipeline devices present in the Pacemakers market. The report helps in developing business strategies by understanding trends shaping and driving the global Pacemakers pipeline landscape.
This report has been prepared by DelveInsight’s analysts after a thorough secondary and primary research into the Pacemaker pipeline. Analysis and estimations are done by taking into consideration industry expert viewpoints of Pacemakers and developmental activities by the companies.
DelveInsight’s ‘Pacemakers -Market Insights, Competitive Landscape and Market Forecast – 2026’ report.
Airway Management Devices Market
DelveInsight’s ‘Airway Management Devices -Market Insights, Competitive Landscape, and Market Forecast – 2026’ report offers epidemiology, treatment and market analysis with rich insights into key companies working in the domain, including Medtronic, Teleflex, Ambu A/S, Smiths Medical, Medline Industries, and others.
Ambulatory Arrhythmia Monitoring Devices Market
DelveInsight’s ‘Ambulatory Arrhythmia monitoring Devices-Market Insights, Competitive Landscape and Market Forecast – 2026’ report offers epidemiology, treatment and market analysis with rich insights into key companies working in the domain, including Biotronik, Abbott Laboratories, Medtronic plc, GE Healthcare, BioTelemetry, Inc., Applied Cardiac Systems, Inc., AliveCor, Inc., Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., Spacelabs Healthcare, among others.
DelveInsight’s ‘Anesthesia Workstation/Machines-Market Insights, Competitive Landscape and Market Forecast 2026’ report offers epidemiology, treatment and market analysis with rich insights into key companies working in the domain, including Carefusion Corporation, Covidien plc, Drägerwerk AG & Co. KGaA, Getinge Group, Fisher & Paykel Healthcare, GE Healthcare, Philips Healthcare, Smiths Medical, DRE Medical, Inc., Teleflex Incorporated, and Masimo Corporation, among others.
Arteriotomy Closure Devices Market
DelveInsight’s ‘Arteriotomy Closure Devices -Market Insights, Competitive Landscape and Market Forecast – 2026’ report offers epidemiology, treatment and market analysis with rich insights into key companies working in the domain, including Abbott Vascular, Cardiva Medical, Arstasis, Cardinal Health, St. Jude Medical, Morris Innovative Research, Scion BioMedical, among others.
3d Cardiac Mapping System Market
DelveInsight’s ‘3D Cardiac Mapping System – Market Insights, Competitive Landscape and Market Forecast –2026’ report offers epidemiology, treatment and market analysis with rich insights into key companies working in the domain, including Biosense Webster, Inc., Jhonson & Jhonson, Boston Scientific Corporation, Inc., Abbott, Kardium, Inc., Medtronic, Catheter Robotics, Inc., Lepu Medical, EP Solutions SA, among others.
Angio Suites Market
DelveInsight’s ‘Angio Suites Market Insights, Competitive Landscape and Market Forecast-2026’ report offers epidemiology, treatment and market analysis with rich insights into key companies working in the domain, including GE Healthcare, Philips Healthcare, Canon Medical Systems Corp., Shimadzu Corp., Siemens Healthcare GmbH, Koninklijke Philips N.V., among others.
Artificial Lung Market
DelveInsight’s ‘Artificial Lung -Market Insights, Competitive Landscape and Market Forecast – 2025’ report offers epidemiology, treatment and market analysis with rich insights into key companies working in the domain, including Xenios, Miromatrix Medical, Lung Biotechnology PBC, Haemair, Michigan Critical Care Consultants, MedArray, Breethe, ALung Technologies, McGowan Institute for Regenerative Medicine, and The Charles Stark Draper Laboratory, among others.
Antibody-mediated Rejection Market
Some of the most promising drugs in the Antibody-mediated rejection market include clazakizumab (CSL Behring), Imlifidase (Hansa Biopharma AB), and VIB4920 (Viela Bio). Learn more about the key companies and emerging market landscape.
Hereditary Deafness Market
Delveinsight’s analysis of Hereditary Loss associated eligible patient population demonstrated that the US accounted for the maximum prevalence, followed by EU5, from the year 2018 to 2026.
Medical Devices and Benign Prostatic Hyperplasia Market
Key companies working in the Benign Prostatic Hyperplasia Market include Olympus Medical, Butterfly Medical, SRS Medical, Teleflex Interventional Urology, Urotronic, Zenflow, ProArc Medical, and Medion Biodesign, among several others.
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.